Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
The American Journal of Managed Care11h
Dr Ruff Explores Mitigating Surgical Bleeding in AFib With Abelacimab
Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.
Neurology Advisor11h
Flossing Linked to Lower Risk for Ischemic, Cardioembolic Stroke, A-Fib
Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation (AF).
medtechdive1d
Boston Scientific closes its year of PFA on a high note
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...
FierceBiotech1d
Boston Scientific clocks over $1B in Farapulse revenue for the afib therapy's first year
Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...
Endocrinology Advisor1d
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib
Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk ...
Baystate Health2d
Anxiety, Heart Palpitations, and AFib: When to Worry
AFib causes an irregular heart rate that can make your heart feel as if it is fluttering or skipping beats. Panic attacks, on ...
Clarivate Plc: Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...